• No results found

Local ablative therapies for colorectal liver metastases and the immune system

N/A
N/A
Protected

Academic year: 2021

Share "Local ablative therapies for colorectal liver metastases and the immune system"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Local ablative therapies for colorectal liver metastases and the

immune system

Duijnhoven, Frederieke van

Citation

Duijnhoven, F. van. (2005, June 22). Local ablative therapies for colorectal liver metastases

and the immune system. Dept. of Surgery, Leiden University Medical Center, Leiden

University. Retrieved from https://hdl.handle.net/1887/2706

Version:

Not Applicable (or Unknown)

License:

Downloaded from:

https://hdl.handle.net/1887/2706

(2)

Local ablative therapies for colorectal liver metastases and the

Local ablative therapies for colorectal liver metastases and the

Local ablative therapies for colorectal liver metastases and the

Local ablative therapies for colorectal liver metastases and the

immune system

immune system

immune system

immune system

Clinical and experimental studies

Proefschrift Proefschrift Proefschrift Proefschrift

ter verkrijging van de graad van Doctor aan de

Universiteit Leiden op gezag van de rector magnificus Dr. D.D. Breimer, hoogleraar in de faculteit der W iskunde en Natuurwetenschappen en die der Geneeskunde, volgens besluit van het college voor promoties te verdedigen op woensdag 22 juni 2005 klokke 14.15 uur

door

Frederieke Hanneke van Duijnhoven Frederieke Hanneke van DuijnhovenFrederieke Hanneke van Duijnhoven Frederieke Hanneke van Duijnhoven

(3)

Promotiecommissie PromotiecommissiePromotiecommissie Promotiecommissie

Promotoren Prof. Dr. O.T. Terpstra

Prof. Dr. R.A.E.M . Tollenaar

Co-promotor Dr. P.J.K. Kuppen

Referent Prof. Dr. A.M .M . Eggermont (Erasmus M edisch Centrum, Rotterdam)

Overige leden Dr. M . van Egmond (VU M edisch Centrum, Amsterdam)

Prof. Dr. G.J. Fleuren

Prof. Dr. T.M . van Gulik (Academisch M edisch Centrum, Amsterdam)

Dr. Ing. J.A. van Oostayen (Ziekenhuis Rijnstate, Arnhem)

Prof. Dr. C.J.H. van de Velde

Research described in this thesis was financially supported by grants from the Drie Lichten foundation, foundation Gastrostart and the Netherlands Organisation for Scientific Research (NWO).

This publication was made possible by financial contributions from Leids Universiteits Fonds (LUF), Integraal Kankercentrum West (IKW), NWO, M edicor, Pfizer, J.E. Jurriaanse Stichting, Tyco Healthcare/M allinckrodt (Valleylab Cool-tip), Janssen-Cilag, KCI M edical and Baxter Bioscience.

Cover: deployed RFA probe, design by www.myriaddesign.nl

ISBN 90-9019541-6

(4)
(5)

Ik ben gedrukt!

Het duurde lang: mijn drukker heeft gekrukt. Maar eindlijk, zie! wat is dat boekjen netjens! Wat zacht papier! wat prettige vinjetjens! Wat is dat bandjen wél gelukt!

Ik ben gedrukt!

Ik ben gedrukt!

Mij dunkt, ik zie heel’t vaderland verrukt, ‘k Neem zitting in Apolloos Priestrenrijen, ‘k Word eerlid der geleerdste Maatschappijen, Daar elke krant mij lauwren plukt,

Ik ben gedrukt!

Ik ben gedrukt!

Toch ga ik onder éne zorg gebukt:

Eén ‘blauwe beul’ kan al mijn vreugd bederven – Papieren kind! uw vader zal ‘t besterven Als u de nijd aan flarden rukt...

Ik ben gedrukt!

(6)

Contents ContentsContents Contents page

Chapter 1 General Introduction 7

Chapter 2 Systemic immune response and established metastases 27

Chapter 3 The effect of photodynamic therapy on distant metastases in vivo 41

Chapter 4 Locoregional therapies of liver metastases and immune response in vivo 61

Chapter 5 Local therapy of colorectal liver metastases and formation of antibodies 77

Chapter 6 Photodynamic therapy with mTHPBC for colorectal liver metastases 89

Chapter 7 Adverse effects of radiofrequency ablation of liver tumours in the Netherlands 107

Chapter 8 Local success rate of radiofrequency ablation of liver metastases 129

Chapter 9 General discussion 145

Summary 155

Samenvatting 161

(7)

Referenties

GERELATEERDE DOCUMENTEN

By suppressing the immune system at time of inoculation of primary liver tumours, the induction of an antitumour immune response during the time the tumour needed to establish

Average number of T cells, immunohistochemically stained by R73 IgG1, in liver tissue surrounding tumours 2 (non-illuminated) and 3 (illuminated) of mTHPC and control rats at 2, 7

The results of this study indicate that a systemic anti-tumour immune response is generated or increased by local treatment with either RFA or PDT of experimental colorectal

Number of tests in separate cell lines showing unchanged, decreased or increased serum levels of antibodies directed against 5 different human colon carcinoma cell lines

Control spiral CT scans were performed according to local protocol and assessed by both the local treating radiologist and an inde- pendent radiologist 9 days and 1 month after

Parameters that were analysed included: age, gender, tumour histology (metastatic lesion vs. HCC), previous liver therapy (local or systemic), number of tumours treated, RFA

For the purpose of this analysis, various parameters were registered that may possibly influence local tumour control rate: patient age, gender, occurrence of metastases

Although tumour specific immune responses in experimental studies are unequivocally present, no reports are available on the immune response in patients treated with local